$11.66 Billion Parkinson's Disease Market Forecast, 2030 by Drug Class, Medical Devices Devices, Route of Administration, Distribution Channel, and Region
October 07, 2024 11:33 ET
|
Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Market by Drug Class, Medical Devices Devices, Route of Administration, Distribution Channel, and Region" report has been added to ...
United States Deep Brain Stimulation Market in Parkinson's Disease Poised for Remarkable Growth through 2029
July 04, 2024 10:19 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "United States Deep Brain Stimulation In Parkinson's Disease Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been...
Global Parkinson Disease Market Projected to Reach $8.8 Billion by 2030, Driven by Advancements and Growing Demand for Effective Treatments
March 28, 2024 11:41 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Parkinson Disease Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Parkinson's Disease Market Outlook: Epidemiology, Treatment, and Pipeline Analysis
August 10, 2023 09:33 ET
|
Research and Markets
Dublin, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The "Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs,...
Parkinson's Disease Industry Assessment and Forecast 2023-2032
July 24, 2023 05:33 ET
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Market Insights, Epidemiology, and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report...
Global Neurology Clinical Trials Market (2021 to 2028) - Featuring IQVIA, Novartis and Covance Among Others
November 02, 2021 08:18 ET
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design...
2021 U.S. Parkinson's Disease Epidemiology Report: 10-year Forecasts of Parkinson's Disease Epidemiology
August 23, 2021 04:18 ET
|
Research and Markets
Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - US Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. The report delivers an...
Global Parkinson's Disease Drug Forecast Report 2021-2029, Featuring Teva, Roche, Prothena, UCB, AbbVie and Norvartis
April 27, 2021 06:28 ET
|
Research and Markets
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Parkinson's Disease - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The global PD...